Generation Bio（NASDAQ: GBIO）报告显示，公司2024年第四季度每股亏损为$(0.32)，符合分析师一致预期。这比去年同期的每股亏损$(0.53)减少了39.62%。公司当季销售额为$4.188万，但未达到分析师一致预期的$2.500百万，相差100.00%。与去年同期的$2.878百万相比，本季度销售额下降了100.00%。

以上内容来自Benzinga Earnings专栏，原文如下：

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 39.62 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $4.188 which missed the analyst consensus estimate of $2.500 million by 100.00 percent. This is a 100.00 percent decrease over sales of $2.878 million the same period last year.